CIRRX
Price
$20.29
Change
+$0.50 (+2.53%)
Updated
Jul 24 closing price
Net Assets
9.61B
SACRX
Price
$9.06
Change
+$0.19 (+2.14%)
Updated
Jul 24 closing price
Net Assets
78.34M
Interact to see
Advertisement

CIRRX vs SACRX

CIRRX vs SACRX Comparison Chart in %
View a ticker or compare two or three
VS
CIRRX vs. SACRX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRRX is a StrongBuy and SACRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRRX has more cash in the bank: 9.61B vs. SACRX (78.3M). SACRX pays higher dividends than CIRRX: SACRX (9.17) vs CIRRX (2.30). CIRRX was incepted earlier than SACRX: CIRRX (12 years) vs SACRX (10 years). SACRX (2.32) is less costly to investors than CIRRX (1.25). CIRRX is a more actively managed with annual turnover of: 27.00 vs. SACRX (8.00). CIRRX has a lower initial minimum investment than SACRX: CIRRX (0) vs SACRX (500). SACRX annual gain was more profitable for investors over the last year : 18.82 vs. CIRRX (15.03). SACRX (13.35) and CIRRX (12.82) have equivalent 5 years return.
CIRRXSACRXCIRRX / SACRX
Total Expense Ratio1.252.3254%
Annual Report Gross Expense Ratio1.252.3254%
Fund Existence12 years10 years-
Gain YTD18.72721.08089%
Front LoadN/AN/A-
Min. Initial Investment0500-
Min. Initial Investment IRAN/AN/A-
Net Assets9.61B78.3M12,272%
Annual Yield % from dividends2.309.1725%
Returns for 1 year15.0318.8280%
Returns for 3 years35.2429.93118%
Returns for 5 years12.8213.3596%
Returns for 10 years60.7542.12144%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVURX9.310.12
+1.31%
American Century Value R
NBNGX27.93-0.14
-0.50%
Sit Mid Cap Growth
RYDHX122.55-0.65
-0.53%
Rydex Dow Jones Industrial Average® H
WBIIX15.88-0.09
-0.56%
William Blair Instl International Gr
PEAPX38.84-0.81
-2.04%
Principal Glb Emerging Markets R3